CTAC NV (CTAC.AS) Stock Fundamental Analysis

AMS:CTAC • NL0000345577

3.05 EUR
+0.11 (+3.74%)
Last: Feb 26, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

5

Overall CTAC gets a fundamental rating of 5 out of 10. We evaluated CTAC against 65 industry peers in the IT Services industry. CTAC has an average financial health and profitability rating. A decent growth rate in combination with a cheap valuation! Better keep an eye on CTAC. Finally CTAC also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • CTAC had positive earnings in the past year.
  • In the past year CTAC had a positive cash flow from operations.
  • In the past 5 years CTAC has always been profitable.
  • In the past 5 years CTAC always reported a positive cash flow from operatings.
CTAC.AS Yearly Net Income VS EBIT VS OCF VS FCFCTAC.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

1.2 Ratios

  • CTAC's Return On Assets of 8.07% is amongst the best of the industry. CTAC outperforms 81.54% of its industry peers.
  • With a decent Return On Equity value of 18.74%, CTAC is doing good in the industry, outperforming 78.46% of the companies in the same industry.
  • CTAC has a Return On Invested Capital (6.80%) which is comparable to the rest of the industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for CTAC is below the industry average of 11.74%.
Industry RankSector Rank
ROA 8.07%
ROE 18.74%
ROIC 6.8%
ROA(3y)4.34%
ROA(5y)4.75%
ROE(3y)10.59%
ROE(5y)12.47%
ROIC(3y)7.72%
ROIC(5y)7.7%
CTAC.AS Yearly ROA, ROE, ROICCTAC.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • CTAC's Profit Margin of 3.10% is in line compared to the rest of the industry. CTAC outperforms 47.69% of its industry peers.
  • CTAC's Profit Margin has improved in the last couple of years.
  • CTAC has a worse Operating Margin (2.97%) than 67.69% of its industry peers.
  • In the last couple of years the Operating Margin of CTAC has grown nicely.
  • CTAC has a worse Gross Margin (37.21%) than 67.69% of its industry peers.
  • In the last couple of years the Gross Margin of CTAC has declined.
Industry RankSector Rank
OM 2.97%
PM (TTM) 3.1%
GM 37.21%
OM growth 3Y-9.69%
OM growth 5Y12.15%
PM growth 3Y-9.09%
PM growth 5Y15.3%
GM growth 3Y-5.24%
GM growth 5Y-3.9%
CTAC.AS Yearly Profit, Operating, Gross MarginsCTAC.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • CTAC has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for CTAC remains at a similar level compared to 1 year ago.
  • The number of shares outstanding for CTAC has been increased compared to 5 years ago.
  • CTAC has a better debt/assets ratio than last year.
CTAC.AS Yearly Shares OutstandingCTAC.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
CTAC.AS Yearly Total Debt VS Total AssetsCTAC.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • CTAC has an Altman-Z score of 3.80. This indicates that CTAC is financially healthy and has little risk of bankruptcy at the moment.
  • CTAC has a better Altman-Z score (3.80) than 80.00% of its industry peers.
  • A Debt/Equity ratio of 0.36 indicates that CTAC is not too dependend on debt financing.
  • CTAC's Debt to Equity ratio of 0.36 is fine compared to the rest of the industry. CTAC outperforms 61.54% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF N/A
Altman-Z 3.8
ROIC/WACC1.05
WACC6.47%
CTAC.AS Yearly LT Debt VS Equity VS FCFCTAC.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.3 Liquidity

  • CTAC has a Current Ratio of 1.00. This is a normal value and indicates that CTAC is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.00, CTAC is not doing good in the industry: 64.62% of the companies in the same industry are doing better.
  • A Quick Ratio of 1.00 indicates that CTAC may have some problems paying its short term obligations.
  • With a Quick ratio value of 1.00, CTAC is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1
Quick Ratio 1
CTAC.AS Yearly Current Assets VS Current LiabilitesCTAC.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 300.00% over the past year.
  • Measured over the past years, CTAC shows a very strong growth in Earnings Per Share. The EPS has been growing by 24.53% on average per year.
  • The Revenue has decreased by -2.28% in the past year.
  • Measured over the past years, CTAC shows a quite strong growth in Revenue. The Revenue has been growing by 8.74% on average per year.
EPS 1Y (TTM)300%
EPS 3Y-5.09%
EPS 5Y24.53%
EPS Q2Q%N/A
Revenue 1Y (TTM)-2.28%
Revenue growth 3Y5.32%
Revenue growth 5Y8.74%
Sales Q2Q%3.33%

3.2 Future

  • CTAC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.55% yearly.
  • CTAC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.12% yearly.
EPS Next Y46.94%
EPS Next 2Y30.93%
EPS Next 3Y21.55%
EPS Next 5YN/A
Revenue Next Year2.42%
Revenue Next 2Y3.37%
Revenue Next 3Y3.63%
Revenue Next 5Y7.12%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CTAC.AS Yearly Revenue VS EstimatesCTAC.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M 150M
CTAC.AS Yearly EPS VS EstimatesCTAC.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2020 2021 2022 2023 2024 2025 2026 2027 0.1 0.2 0.3 0.4

More info and screens

Find the best growth stocksShow best growing peers

7

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 10.89, which indicates a very decent valuation of CTAC.
  • Based on the Price/Earnings ratio, CTAC is valued cheaper than 87.69% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of CTAC to the average of the S&P500 Index (27.11), we can say CTAC is valued rather cheaply.
  • CTAC is valuated cheaply with a Price/Forward Earnings ratio of 7.12.
  • Based on the Price/Forward Earnings ratio, CTAC is valued cheaper than 90.77% of the companies in the same industry.
  • CTAC is valuated cheaply when we compare the Price/Forward Earnings ratio to 28.13, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 10.89
Fwd PE 7.12
CTAC.AS Price Earnings VS Forward Price EarningsCTAC.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CTAC is valued cheaper than 86.15% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.47
CTAC.AS Per share dataCTAC.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as CTAC's earnings are expected to grow with 21.55% in the coming years.
PEG (NY)0.23
PEG (5Y)0.44
EPS Next 2Y30.93%
EPS Next 3Y21.55%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. Dividend

5.1 Amount

  • CTAC has a Yearly Dividend Yield of 3.67%. Purely for dividend investing, there may be better candidates out there.
  • CTAC's Dividend Yield is a higher than the industry average which is at 2.72.
  • CTAC's Dividend Yield is rather good when compared to the S&P500 average which is at 1.80.
Industry RankSector Rank
Dividend Yield 3.67%

5.2 History

  • On average, the dividend of CTAC grows each year by 17.42%, which is quite nice.
Dividend Growth(5Y)17.42%
Div Incr Years0
Div Non Decr Years1
CTAC.AS Yearly Dividends per shareCTAC.AS Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.02 0.04 0.06 0.08 0.1

5.3 Sustainability

  • CTAC pays out 26.85% of its income as dividend. This is a sustainable payout ratio.
  • CTAC's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP26.85%
EPS Next 2Y30.93%
EPS Next 3Y21.55%
CTAC.AS Yearly Income VS Free CF VS DividendCTAC.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M
CTAC.AS Dividend Payout.CTAC.AS Dividend Payout, showing the Payout Ratio.CTAC.AS Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

CTAC NV

AMS:CTAC (2/26/2026, 7:00:00 PM)

3.05

+0.11 (+3.74%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners6.76%
Inst Owner ChangeN/A
Ins Owners22.27%
Ins Owner ChangeN/A
Market Cap43.16M
Revenue(TTM)188.22M
Net Income(TTM)5.81M
Analysts80
Price Target2.87 (-5.9%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.67%
Yearly Dividend0.11
Dividend Growth(5Y)17.42%
DP26.85%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.44%
PT rev (3m)-3.44%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-4.51%
Revenue NY rev (3m)-4.51%
Valuation
Industry RankSector Rank
PE 10.89
Fwd PE 7.12
P/S 0.23
P/FCF N/A
P/OCF 20.95
P/B 1.39
P/tB 8.63
EV/EBITDA 4.47
EPS(TTM)0.28
EY9.18%
EPS(NY)0.43
Fwd EY14.05%
FCF(TTM)-0.12
FCFYN/A
OCF(TTM)0.15
OCFY4.77%
SpS13.23
BVpS2.19
TBVpS0.35
PEG (NY)0.23
PEG (5Y)0.44
Graham Number3.72
Profitability
Industry RankSector Rank
ROA 8.07%
ROE 18.74%
ROCE 14.63%
ROIC 6.8%
ROICexc 7.19%
ROICexgc 19.37%
OM 2.97%
PM (TTM) 3.1%
GM 37.21%
FCFM N/A
ROA(3y)4.34%
ROA(5y)4.75%
ROE(3y)10.59%
ROE(5y)12.47%
ROIC(3y)7.72%
ROIC(5y)7.7%
ROICexc(3y)9.79%
ROICexc(5y)10.06%
ROICexgc(3y)82.95%
ROICexgc(5y)110.67%
ROCE(3y)14.7%
ROCE(5y)14.69%
ROICexgc growth 3Y-17.16%
ROICexgc growth 5Y33.25%
ROICexc growth 3Y-3.08%
ROICexc growth 5Y14.74%
OM growth 3Y-9.69%
OM growth 5Y12.15%
PM growth 3Y-9.09%
PM growth 5Y15.3%
GM growth 3Y-5.24%
GM growth 5Y-3.9%
F-Score6
Asset Turnover2.6
Health
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF N/A
Debt/EBITDA 1.03
Cap/Depr 69.59%
Cap/Sales 1.99%
Interest Coverage 14.26
Cash Conversion 18.86%
Profit Quality N/A
Current Ratio 1
Quick Ratio 1
Altman-Z 3.8
F-Score6
WACC6.47%
ROIC/WACC1.05
Cap/Depr(3y)40.77%
Cap/Depr(5y)30.88%
Cap/Sales(3y)1.72%
Cap/Sales(5y)1.4%
Profit Quality(3y)410.26%
Profit Quality(5y)379.1%
High Growth Momentum
Growth
EPS 1Y (TTM)300%
EPS 3Y-5.09%
EPS 5Y24.53%
EPS Q2Q%N/A
EPS Next Y46.94%
EPS Next 2Y30.93%
EPS Next 3Y21.55%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.28%
Revenue growth 3Y5.32%
Revenue growth 5Y8.74%
Sales Q2Q%3.33%
Revenue Next Year2.42%
Revenue Next 2Y3.37%
Revenue Next 3Y3.63%
Revenue Next 5Y7.12%
EBIT growth 1Y12.1%
EBIT growth 3Y-4.89%
EBIT growth 5Y21.95%
EBIT Next Year66.67%
EBIT Next 3Y25.99%
EBIT Next 5YN/A
FCF growth 1Y-117.59%
FCF growth 3Y-8.31%
FCF growth 5Y-0.45%
OCF growth 1Y-82.03%
OCF growth 3Y1.58%
OCF growth 5Y4.33%

CTAC NV / CTAC.AS FAQ

What is the fundamental rating for CTAC stock?

ChartMill assigns a fundamental rating of 5 / 10 to CTAC.AS.


Can you provide the valuation status for CTAC NV?

ChartMill assigns a valuation rating of 7 / 10 to CTAC NV (CTAC.AS). This can be considered as Undervalued.


Can you provide the profitability details for CTAC NV?

CTAC NV (CTAC.AS) has a profitability rating of 5 / 10.


What is the financial health of CTAC NV (CTAC.AS) stock?

The financial health rating of CTAC NV (CTAC.AS) is 4 / 10.


Can you provide the dividend sustainability for CTAC stock?

The dividend rating of CTAC NV (CTAC.AS) is 7 / 10 and the dividend payout ratio is 26.85%.